Regulatory

CDSCO Licensing Explained: Choosing the Right Pathway

A plain-English walkthrough of how medical devices and IVDs are licensed in India — device classification, import vs. manufacturing routes, and how to pick the form that actually fits your product.

BT

Bio-State Team

Regulatory affairs

May 20, 20267 min read
Regulatory

TL;DR

  • A plain-English walkthrough of how medical devices and IVDs are licensed in India — device classification, import vs.
  • manufacturing routes, and how to pick the form that actually fits your product.
Table of contents (3)

Start with risk classification

Every CDSCO pathway begins with one question: what risk class is your device? India classifies devices and IVDs into four risk classes — A (lowest), B, C, and D (highest). The class decides which authority handles your file and which form you submit.

  • Class A & B → State Licensing Authority
  • Class C & D → Central Licensing Authority
  • Import of any class → Central Licensing Authority (Form MD-14 → MD-15)
Regulatory

Import vs. manufacturing

If you are bringing a finished device into India, you are on the import track and will need an Authorised Indian Agent to hold the licence. If you are making the device in India, you are on the manufacturing track (MD-5 for Class A/B, MD-9 for Class C/D).

The single most expensive mistake we see is applying on the wrong track. Confirm your classification before a single dossier page is written.

A simple decision sequence

  • Confirm the risk class against the CDSCO notified-device list.
  • Decide import vs. manufacture based on where the device is finished.
  • Map the correct form, then build the dossier around its checklist.

Get these three right and the rest of the journey — queries, audits, endorsements — becomes a process rather than a surprise.

Found this useful? Share with your team:

Need help applying this to your project?

A 30-minute consultation will tell you exactly how this affects your device.

Book a Consultation